230 related articles for article (PubMed ID: 12891957)
1. National drug bill to continue rising by 14%-18%.
Manag Care; 2003 Jul; 12(7):52. PubMed ID: 12891957
[No Abstract] [Full Text] [Related]
2. By the numbers. The rising costs of prescription drugs.
Thornton D
Healthplan; 1999; 40(5):71-2. PubMed ID: 10622972
[No Abstract] [Full Text] [Related]
3. Study shows increases in drug costs may be justified by improvements in outcomes.
Capitation Rates Data; 2000 Jun; 5(6):65-8. PubMed ID: 11067438
[No Abstract] [Full Text] [Related]
4. Prescription costs become harder to swallow. Providers and payers get a big dose of reality with explosive spending and patient demand for new drugs.
Hensley S
Mod Healthc; 1999 Aug; 29(34):30-4. PubMed ID: 10557476
[TBL] [Abstract][Full Text] [Related]
5. Drug spending keeps rising, but rate of increase slowing.
Capitation Rates Data; 2001 Aug; 6(8):85-9. PubMed ID: 11526857
[No Abstract] [Full Text] [Related]
6. DataWatch. Demystifying the drug spend.
Bus Health; 2000; 18(7):46. PubMed ID: 11185085
[No Abstract] [Full Text] [Related]
7. Managed care is helping to slow growth in health care spending, but health care's share of the economy keeps on growing anyway.
Manag Care; 1995 Apr; 4(4):54. PubMed ID: 10142071
[No Abstract] [Full Text] [Related]
8. Drugs still influence health costs, but trend abating.
Capitation Rates Data; 2003 Oct; 8(10):114-20. PubMed ID: 14621548
[No Abstract] [Full Text] [Related]
9. National health expenditures, 1998.
Cowan CA; Lazenby HC; Martin AB; McDonnell PA; Sensenig AL; Stiller JM; Whittle LS; Kotova KA; Zezza MA; Donham CS; Long AM; Stewart MW
Health Care Financ Rev; 1999; 21(2):165-210. PubMed ID: 11481774
[TBL] [Abstract][Full Text] [Related]
10. Data watch. The scoop on Rx drug spending.
Bus Health; 2001 Jun; 19(6):48. PubMed ID: 11434100
[No Abstract] [Full Text] [Related]
11. Prescription drug expenditures rising--too fast?
CMAJ; 2005 May; 172(10):1261, 1263. PubMed ID: 15883389
[No Abstract] [Full Text] [Related]
12. National health expenditures, 1997.
Braden BR; Cowan CA; Lazenby HC; Martin AB; McDonnell PA; Sensenig AL; Stiller JM; Whittle LS; Donham CS; Long AM; Stewart MW
Health Care Financ Rev; 1998; 20(1):83-126. PubMed ID: 10387428
[TBL] [Abstract][Full Text] [Related]
13. MCO-PBM (managed care organization-prescription benefit management) partnerships holding down drug trend.
Alexander W
Exec Solut Healthc Manag; 1998 Dec; 1(10):1, 4-6. PubMed ID: 10338773
[No Abstract] [Full Text] [Related]
14. 1996 medical expenses as a percentage of premium revenues for selected national health plans.
Healthc Financ Manage; 1997 Nov; 51(11):20. PubMed ID: 10174765
[No Abstract] [Full Text] [Related]
15. Ancillary, outpatient costs driving commercial premium increases.
Capitation Rates Data; 2002 Nov; 7(11):127-30. PubMed ID: 12474420
[No Abstract] [Full Text] [Related]
16. Another theory about healthcare expenditures and inflation refuted by the facts.
Bloom BS
Am J Manag Care; 2001 Jul; 7(7):740-1. PubMed ID: 11464431
[No Abstract] [Full Text] [Related]
17. Improving the PPI sample for prescription pharmaceuticals.
Kelly GG
Mon Labor Rev; 1997 Oct; 120(10):10-7. PubMed ID: 10176326
[No Abstract] [Full Text] [Related]
18. Drug cost increases are generated by the 50 top selling pharmaceuticals.
Health Care Strateg Manage; 2001 Jun; 19(6):14-5, 1. PubMed ID: 11409091
[TBL] [Abstract][Full Text] [Related]
19. 2009 costs will continue to outpace inflation.
Manag Care; 2009 Jan; 18(1):50. PubMed ID: 19186673
[No Abstract] [Full Text] [Related]
20. Behavioral health costs, drugs rising faster than those for physical health.
Capitation Rates Data; 2005 May; 10(5):58-60. PubMed ID: 16114826
[No Abstract] [Full Text] [Related]
[Next] [New Search]
